CLEVELAND and TOKYO, Nov. 21 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (Nasdaq: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today reported that its alliance partner in Japan, NTT DATA Corporation, has placed its first self-designed project using the DATATRAK eClinical platform into production for a Japanese clinical trial. The successful rollout of this first independently designed clinical trial followed a successful completion of an Enterprise Transfer Program from DATATRAK.
Through DATATRAK's Enterprise Transfer Program, any client can become independent in the rollout of electronic clinical trials with the Company's eClinical platform. At this time, all Enterprise Transfer clients continue to host their projects through DATATRAK's state-of-the-art global data center; however, because of advancements with the eClinical platform from the Development Team, it will soon be possible for clients to utilize an optional business approach of hosting their own studies and licensing the product suite for multi-year periods.
"The strength of the product suite from DATATRAK and their valuable experience in performing many global clinical trials was critical to the success of our joint efforts with this project for our Japanese customer," stated Hiroto Ohno, Senior Manager of Healthcare System Sector for NTT DATA Corporation. "We look forward to deploying many more electronic clinical trials in this market with DATATRAK eClinical."
"Our Team has been working closely with NTT DATA with the goal of
empowering them to be independent with our platform so that both companies can
gain increasing traction in the Japanese clinical trial market," stated Dr.
Jeffrey A. Green, Chief Executive Officer of DATATRAK International, Inc.
|SOURCE DATATRAK International, Inc.|
Copyright©2008 PR Newswire.
All rights reserved